Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Feb;64(2):184–189. doi: 10.1136/jnnp.64.2.184

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

G Wenning 1, I Litvan 1, J Jankovic 1, R Granata 1, C Mangone 1, A McKee 1, W Poewe 1, K Jellinger 1, K Chaudhuri 1, L D'Olhaberriague 1, R Pearce 1
PMCID: PMC2169933  PMID: 9489528

Abstract

OBJECTIVE—To analyse the natural history and survival of corticobasal degeneration by investigating the clinical features of 14 cases confirmed by postmortem examination.
METHODS—Patients with definite corticobasal degeneration were selected from the research and clinical files of seven tertiary medical centres in Austria, the United Kingdom, and the United States. Clinical features were analysed in detail.
RESULTS—The sample consisted of eight female and six male patients; mean age at symptom onset was 63 (SD 7.7) years, and mean disease duration was 7.9 (SD 2.6) years. The most commonly reported symptom at onset included asymmetric limb clumsiness with or without rigidity (50%) or tremor (21%). At the first neurological visit, on average 3.0 (SD 1.9) years after symptom onset, the most often encountered extrapyramidal features included unilateral limb rigidity (79%) or bradykinesia (71%), postural imbalance (45%), and unilateral limb dystonia (43%). Ideomotor apraxia (64%), and to a lesser extent cortical dementia (36%), were the most common cortical signs present at the first visit. During the course of the disease, virtually all patients developed asymmetric or unilateral akinetic rigid parkinsonism and a gait disorder. No patient had a dramatic response to levodopa therapy. Median survival time after onset of symptoms was 7.9 (SD 0.7) (range, 2.5-12.5) years, and, after the first clinic visit, 4.9 (SD 0.7) (range, 0.8-10) years. Early bilateral bradykinesia, frontal syndrome, or two out of tremor, rigidity, and bradykinesia, predicted a shorter survival.
CONCLUSION—The results confirm that unilateral parkinsonism unresponsive to levodopa and limb ideomotor apraxia are the clinical hallmarks of corticobasal degeneration, and only a minority of patients with corticobasal degeneration present with dementia. The study also suggests that a focal cognitive and extrapyramidal motor syndrome is indicative of corticobasal degeneration. Survival in corticobasal degeneration was shortened by the early presence of (more) widespread parkinsonian features or frontal lobe syndrome.



Full Text

The Full Text of this article is available as a PDF (110.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Shlomo Y., Wenning G. K., Tison F., Quinn N. P. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology. 1997 Feb;48(2):384–393. doi: 10.1212/wnl.48.2.384. [DOI] [PubMed] [Google Scholar]
  2. Bergeron C., Pollanen M. S., Weyer L., Black S. E., Lang A. E. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol. 1996 Dec;40(6):893–900. doi: 10.1002/ana.410400611. [DOI] [PubMed] [Google Scholar]
  3. Blin J., Vidailhet M. J., Pillon B., Dubois B., Feve J. R., Agid Y. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord. 1992 Oct;7(4):348–354. doi: 10.1002/mds.870070409. [DOI] [PubMed] [Google Scholar]
  4. Brooks D. J. PET studies on the early and differential diagnosis of Parkinson's disease. Neurology. 1993 Dec;43(12 Suppl 6):S6–16. [PubMed] [Google Scholar]
  5. Brunt E. R., van Weerden T. W., Pruim J., Lakke J. W. Unique myoclonic pattern in corticobasal degeneration. Mov Disord. 1995 Mar;10(2):132–142. doi: 10.1002/mds.870100203. [DOI] [PubMed] [Google Scholar]
  6. Doody R. S., Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry. 1992 Sep;55(9):806–810. doi: 10.1136/jnnp.55.9.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frisoni G. B., Pizzolato G., Zanetti O., Bianchetti A., Chierichetti F., Trabucchi M. Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis. Eur Neurol. 1995;35(1):50–54. doi: 10.1159/000117090. [DOI] [PubMed] [Google Scholar]
  8. Hauw J. J., Daniel S. E., Dickson D., Horoupian D. S., Jellinger K., Lantos P. L., McKee A., Tabaton M., Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994 Nov;44(11):2015–2019. doi: 10.1212/wnl.44.11.2015. [DOI] [PubMed] [Google Scholar]
  9. Leiguarda R. C., Pramstaller P. P., Merello M., Starkstein S., Lees A. J., Marsden C. D. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain. 1997 Jan;120(Pt 1):75–90. doi: 10.1093/brain/120.1.75. [DOI] [PubMed] [Google Scholar]
  10. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R. C., Goetz C. G., Golbe L. I., Grafman J., Growdon J. H. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996 Jul;47(1):1–9. doi: 10.1212/wnl.47.1.1. [DOI] [PubMed] [Google Scholar]
  11. Litvan I., Agid Y., Goetz C., Jankovic J., Wenning G. K., Brandel J. P., Lai E. C., Verny M., Ray-Chaudhuri K., McKee A. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997 Jan;48(1):119–125. doi: 10.1212/wnl.48.1.119. [DOI] [PubMed] [Google Scholar]
  12. Litvan I., Mangone C. A., McKee A., Verny M., Parsa A., Jellinger K., D'Olhaberriague L., Chaudhuri K. R., Pearce R. K. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1996 Jun;60(6):615–620. doi: 10.1136/jnnp.60.6.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Markus H. S., Lees A. J., Lennox G., Marsden C. D., Costa D. C. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord. 1995 Mar;10(2):179–187. doi: 10.1002/mds.870100208. [DOI] [PubMed] [Google Scholar]
  14. Rinne J. O., Lee M. S., Thompson P. D., Marsden C. D. Corticobasal degeneration. A clinical study of 36 cases. Brain. 1994 Oct;117(Pt 5):1183–1196. doi: 10.1093/brain/117.5.1183. [DOI] [PubMed] [Google Scholar]
  15. Savoiardo M., Girotti F., Strada L., Ciceri E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm Suppl. 1994;42:93–110. doi: 10.1007/978-3-7091-6641-3_8. [DOI] [PubMed] [Google Scholar]
  16. Sawle G. V., Brooks D. J., Marsden C. D., Frackowiak R. S. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain. 1991 Feb;114(Pt 1B):541–556. doi: 10.1093/brain/114.1.541. [DOI] [PubMed] [Google Scholar]
  17. Schneider J. A., Watts R. L., Gearing M., Brewer R. P., Mirra S. S. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997 Apr;48(4):959–969. doi: 10.1212/wnl.48.4.959. [DOI] [PubMed] [Google Scholar]
  18. Thompson P. D., Day B. L., Rothwell J. C., Brown P., Britton T. C., Marsden C. D. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain. 1994 Oct;117(Pt 5):1197–1207. doi: 10.1093/brain/117.5.1197. [DOI] [PubMed] [Google Scholar]
  19. Vidailhet M., Rivaud S., Gouider-Khouja N., Pillon B., Bonnet A. M., Gaymard B., Agid Y., Pierrot-Deseilligny C. Eye movements in parkinsonian syndromes. Ann Neurol. 1994 Apr;35(4):420–426. doi: 10.1002/ana.410350408. [DOI] [PubMed] [Google Scholar]
  20. Wenning G. K., Ben-Shlomo Y., Magalhães M., Daniel S. E., Quinn N. P. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):160–166. doi: 10.1136/jnnp.58.2.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wenning G. K., Pramstaller P. P., Ransmayr G., Poewe W. Atypische Parkinson-Syndrome. Nervenarzt. 1997 Feb;68(2):102–115. doi: 10.1007/s001150050104. [DOI] [PubMed] [Google Scholar]
  22. Wenning G. K., Tison F., Ben Shlomo Y., Daniel S. E., Quinn N. P. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997 Mar;12(2):133–147. doi: 10.1002/mds.870120203. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES